168 related articles for article (PubMed ID: 38185613)
1. Current updates in sarcoma biomarker discovery: emphasis on next-generation sequencing-based methods.
Patton A; Dermawan JK
Pathology; 2024 Mar; 56(2):274-282. PubMed ID: 38185613
[TBL] [Abstract][Full Text] [Related]
2. Advances in sarcoma molecular diagnostics.
Wang XQ; Goytain A; Dickson BC; Nielsen TO
Genes Chromosomes Cancer; 2022 Jun; 61(6):332-345. PubMed ID: 35064596
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.
Hameed M
Expert Rev Mol Diagn; 2014 Nov; 14(8):961-77. PubMed ID: 25109831
[TBL] [Abstract][Full Text] [Related]
4. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract][Full Text] [Related]
5. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
[TBL] [Abstract][Full Text] [Related]
6. Molecular Alterations in Pediatric Fibroblastic/Myofibroblastic Tumors: An Appraisal of a Next Generation Sequencing Assay in a Retrospective Single Centre Study.
Slack JC; Bründler MA; Nohr E; McIntyre JB; Kurek KC
Pediatr Dev Pathol; 2021; 24(5):405-421. PubMed ID: 33970051
[TBL] [Abstract][Full Text] [Related]
7. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
[TBL] [Abstract][Full Text] [Related]
8. What Would Next Generation Sequencing Bring to the Diagnosis and Treatment of Sarcomas? A Series of 20 Cases, a Single Institution's Experience.
Kulaç İ; Bulutay P; Meriçöz ÇA
Turk Patoloji Derg; 2021; 37(3):226-232. PubMed ID: 34514574
[TBL] [Abstract][Full Text] [Related]
9. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
Szurian K; Kashofer K; Liegl-Atzwanger B
Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
[TBL] [Abstract][Full Text] [Related]
11. Complementary value of molecular analysis to expert review in refining classification of uncommon soft tissue tumors.
Suurmeijer AJH; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23196. PubMed ID: 37702439
[TBL] [Abstract][Full Text] [Related]
12. [The necessity and urgency of molecular analysis in the diagnosis and treatment of bone and soft tissue sarcomas].
Niu XH; Xu HR
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2399-2404. PubMed ID: 36000368
[TBL] [Abstract][Full Text] [Related]
13. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
Marino-Enriquez A
Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
[TBL] [Abstract][Full Text] [Related]
14. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
15. Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors.
de Álava E
Virchows Arch; 2024 Feb; 484(2):353-367. PubMed ID: 38228904
[TBL] [Abstract][Full Text] [Related]
16. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.
Li X; Seebacher NA; Hornicek FJ; Xiao T; Duan Z
Cancer Lett; 2018 Dec; 439():66-77. PubMed ID: 30223067
[TBL] [Abstract][Full Text] [Related]
17. Targeted RNA sequencing: A routine ancillary technique in the diagnosis of bone and soft tissue neoplasms.
Dickson BC; Swanson D
Genes Chromosomes Cancer; 2019 Feb; 58(2):75-87. PubMed ID: 30350361
[TBL] [Abstract][Full Text] [Related]
18. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
Italiano A; Dinart D; Soubeyran I; Bellera C; Espérou H; Delmas C; Mercier N; Albert S; Poignie L; Boland A; Bourdon A; Geneste D; Cavaille Q; Laizet Y; Khalifa E; Auzanneau C; Squiban B; Truffaux N; Olaso R; Gerber Z; Wallet C; Bénard A; Blay JY; Laurent-Puig P; Deleuze JF; Lucchesi C; Mathoulin-Pelissier S;
BMC Cancer; 2021 Nov; 21(1):1180. PubMed ID: 34740331
[TBL] [Abstract][Full Text] [Related]
20. Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?
Davis JL; Rudzinski ER
Curr Treat Options Oncol; 2020 Sep; 21(11):90. PubMed ID: 32875423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
